Discover a study where researchers have discovered a myeloid-derived antigen-presenting cells population essential for peripherally induced regulatory T cells.

Many different cancer treatments work to directly target the tumor or the cells around it. The immediate goal is to mitigate ...

T-cell activation involves two phases, enabling a more precise immune response. This insight may boost cancer immunotherapy ...

IDO1 and PDL1 are immune checkpoints with key roles in immune system regulation. Their relevance stems from their ability to suppress T-cell function. T-cells are vital to the body’s immune response ...

RNA-based technologies are a powerful molecular biology toolbox, empowering scientists to decipher the complexities of living ...

ImmunityBio, Inc. , a leading immunotherapy company, will announce new clinical findings for ANKTIVA® (nogapendekin alfa inbakicept-pmln) in non-muscle invasive bladder cancer carcinoma in situ (NMIBC ...

Learning is something everyone does daily—mastering new skills at work, remembering song lyrics, or following directions to ...

Apr. 10, 2025 — Research has shed light on how a new type of antibody treatment reactivates patients' immune cells to fight ovarian ... New Phase of the Immune Response Uncovered Apr. 10 ...

In the recent decades, there has been an increase in the aging population across the world coupled with declining birth rates and an increased lifespan of individuals. The proportion of the ...

An NIH-funded project leverages advanced synapse imaging to monitor real-time neuronal changes during learning, unveiling new ...

Reductions in the number and proportion of lymphocytes and their cytokine production, depression of dendritic cells function and T-cell activation, and finally reduction in numbers of monocytes ...